Search - tctmd.com

Displaying 341 - 360 of 554

Sort: Relevancy | Date

News Conference News TCT 2015

Mortality Increasing in Elderly PCI Patients

October 12, 2015

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Conference News TCT 2015

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

October 11, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Industry News

Drug Shortage Update: Eptifibatide Injection

September 23, 2015

News Industry News

Miracor Medical Systems Launches PiCSO® Impulse System in Asia

September 21, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Conference News ESC 2015

CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI

L.A. McKeown

August 30, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Daily News

肌钙蛋白 T 水平高预示着 2 型糖尿病及稳定型心脏疾病患者结局不佳

Todd Neale

August 17, 2015

News Daily News

Los Niveles Altos de Troponina T Pronostican Malos Resultados en Pacientes Con Diabetes Tipo 2 y Cardiopatía Estable

Todd Neale

August 17, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Daily News

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

Todd Neale

July 27, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

Advertisement

Mortality Increasing in Elderly PCI Patients

Despite Setbacks, Research Into Myocardial Salvage Continues

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

Novel Devices Present New Treatment Options for STEMI

Drug Shortage Update: Eptifibatide Injection

Miracor Medical Systems Launches PiCSO® Impulse System in Asia

Ventrix Initiates Clinical Trial of VentriGel™

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

肌钙蛋白 T 水平高预示着 2 型糖尿病及稳定型心脏疾病患者结局不佳

Los Niveles Altos de Troponina T Pronostican Malos Resultados en Pacientes Con Diabetes Tipo 2 y Cardiopatía Estable

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content